
| For Immediate Release |
Press
Release
|
|
Contact:
|
Raiford
Garrabrant
|
|
Cree,
Inc.
|
|
|
Director,
Investor Relations
|
|
|
Ph:
919-287-7895
|
|
|
Fax:
919-313-5615
|
|
|
Email:
raiford_garrabrant@cree.com
|
| Ø |
Announced
volume availability of the LR24, a recessed LED luminaire that offers
high-quality, energy-efficient light for the largest commercial lighting
market, suspended-ceiling applications traditionally addressed by linear
fluorescents. The LR24 has already been installed at the U.S.
Federal Reserve in Washington, D.C., as part of their ongoing
energy-efficiency program, and the Pentagon plans to install 4,200 of the
luminaires as part of a major renovation currently
underway.
|
| Ø |
Announced
the high-volume availability of XLamp XP-E LEDs with output up to 122
lumens, the highest commercially available minimum flux for a single-die
LED, at 350mA, in the industry today. The volume availability
of these XLamp LEDs is aimed at further stimulating the LED lighting
market, driving applications in outdoor and indoor general illumination as
well as portable and retail display
lighting.
|
| Ø |
Achieved
industry-best reported R&D results of 161 lumens per watt for a white
power LED. These results demonstrate Cree’s continued
commitment to deliver industry-leading performance through a constant
focus on innovation and
R&D.
|
| Ø |
Entered
into a patent license agreement granting Mitsubishi Chemical Corporation
(MCC) an exclusive license (subject to certain exceptions) to manufacture
and sell freestanding GaN substrates, with Cree to receive over the life
of the agreement a combination of guaranteed payments and royalties on the
sale of GaN substrates.
|
| Ø |
Agreed
with Bridgelux, Inc. to settle the parties' patent infringement litigation
and to dismiss all claims and counterclaims in the suits. As
part of the settlement, Cree granted Bridgelux a license to the Cree and
Boston University patents at issue in the litigation, and Bridgelux agreed
to pay a license fee and royalties. In addition, Bridgelux and
Cree have entered into a supply agreement under which Cree will become a
significant supplier to
Bridgelux.
|
| Ø |
Welcomed Indian Wells,
California, to the LED City® Program. The city has
replaced much of the lighting in City Hall, with all circular recessed
lighting converted to the Cree LR6 LED light, reducing electricity
consumption by 80%. The city plans to evaluate LED lighting for
other municipal lighting applications to further increase energy
savings.
|
| Ø |
Welcomed Notre Dame, Madison Area
Technical College, and the University of California, Davis to the LED
University™
Program. Notre Dame is implementing four pilot installations to
evaluate the feasibility of LED lighting across the campus, and is already
realizing energy savings of 81% compared to incandescent lighting in the
Hesburgh
Library.
|
| Ø |
GAAP
gross margin was 38% of revenue compared to 35% in Q2 of fiscal 2008, and
non-GAAP gross margin was 39% compared to 36% in Q2 of fiscal
2008. Q2 gross margin included approximately 200 basis points
of benefit related to the MCC and Bridgelux license
agreements.
|
| Ø |
Accounts
receivable increased $5.1 million from Q1 of fiscal 2009 to $108.6
million, resulting in days sales outstanding of 66, the same as Q1 of
fiscal 2009.
|
| Ø |
Inventory
decreased $0.4 million from Q1 of fiscal 2009 to $78.8 million, and
represents 78 days of inventory, the same as Q1 of fiscal
2009.
|
| Ø |
Cash
and investments increased $26.5 million to $365.5 million, with cash flow
from operations of $40.7 million and free cash flow (cash flow from
operations less capital expenditures) of $23.2
million.
|
|
CREE,
INC.
|
||||||||||||
|
CONSOLIDATED
STATEMENTS OF INCOME
|
||||||||||||
|
(in
thousands, except per share data)
|
||||||||||||
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||
|
December
28,
|
December
30,
|
December
28,
|
December
30,
|
|||||||||
|
2008
|
2007
|
2008
|
2007
|
|||||||||
| (Unaudited) | (Unaudited) | |||||||||||
|
Product
revenue
|
$ | 137,595 | $ | 111,341 | $ | 272,288 | $ | 217,304 | ||||
|
Contract
revenue
|
4,446 | 7,658 | 10,131 | 15,081 | ||||||||
|
Up-front
license fees
|
5,582 | - | 5,582 | - | ||||||||
|
Total
revenue
|
147,623 | 118,999 | 288,001 | 232,385 | ||||||||
|
Cost
of product revenue
|
86,831 | 71,251 | 173,475 | 143,831 | ||||||||
|
Cost
of contract revenue
|
3,790 | 5,952 | 8,161 | 12,018 | ||||||||
|
Up-front
license fees
|
506 | - | 506 | - | ||||||||
|
Total
cost of revenue
|
91,127 | 77,203 | 182,142 | 155,849 | ||||||||
|
Gross
profit
|
56,496 | 41,796 | 105,859 | 76,536 | ||||||||
|
Gross
margin percentage
|
38.3 | % | 35.1 | % | 36.8 | % | 32.9 | % | ||||
|
Operating
expenses:
|
||||||||||||
|
Research
and development
|
18,441 | 14,901 | 35,716 | 27,678 | ||||||||
|
Sales,
general and administrative
|
21,843 | 18,211 | 44,761 | 36,373 | ||||||||
|
Amortization
of acquisition related intangibles
|
4,062 | 4,048 | 8,124 | 8,096 | ||||||||
|
Loss
on disposal and impairment of long-lived assets
|
645 | 474 | 1,050 | 1,209 | ||||||||
|
Total
operating expenses
|
44,991 | 37,634 | 89,651 | 73,356 | ||||||||
|
Operating
income
|
11,505 | 4,162 | 16,208 | 3,180 | ||||||||
|
Operating
income percentage
|
7.8 | % | 3.5 | % | 5.6 | % | 1.4 | % | ||||
|
Non-operating
income:
|
||||||||||||
|
Gain
on sale of investments, net
|
53 | - | 65 | 14,117 | ||||||||
|
Interest
and other non-operating income, net
|
2,507 | 4,582 | 5,484 | 8,309 | ||||||||
|
Income
from continuing operations before income taxes
|
14,065 | 8,744 | 21,757 | 25,606 | ||||||||
|
Income
tax expense
|
3,218 | 2,104 | 4,972 | 6,098 | ||||||||
|
Net
income from continuing operations
|
10,847 | 6,640 | 16,785 | 19,508 | ||||||||
|
Loss
from discontinued operations, net of related tax effect
|
(151 | ) | (20 | ) | (170 | ) | (174 | ) | ||||
|
Net
income
|
$ | 10,696 | $ | 6,620 | $ | 16,615 | $ | 19,334 | ||||
|
Diluted
earnings per share:
|
||||||||||||
|
Income
from continuing operations
|
$ | 0.12 | $ | 0.08 | $ | 0.19 | $ | 0.22 | ||||
|
Loss
from discontinued operations
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
|
Net
income
|
$ | 0.12 | $ | 0.08 | $ | 0.19 | $ | 0.22 | ||||
|
Weighted
average shares of common
|
||||||||||||
|
stock
outstanding, basic
|
88,057 | 85,190 | 87,954 | 84,936 | ||||||||
|
Weighted
average shares of common
|
||||||||||||
|
stock
outstanding, diluted
|
88,511 | 86,848 | 88,619 | 86,713 | ||||||||
|
CREE,
INC.
|
|||||||
|
CONSOLIDATED
BALANCE SHEETS
|
|||||||
|
(in
thousands)
|
|||||||
|
December
28,
|
June
29,
|
||||||
|
2008
|
2008
|
||||||
|
(Unaudited)
|
|
||||||
|
Assets:
|
|||||||
|
Current
assets:
|
|||||||
|
Cash, cash equivalents and short
term investments
|
$ | 322,193 | $ | 312,428 | |||
|
Accounts receivable,
net
|
108,552 | 110,376 | |||||
|
Inventory,
net
|
78,816 | 80,161 | |||||
|
Income taxes
receivable
|
18,064 | 9,825 | |||||
|
Deferred income
taxes
|
5,032 | 4,578 | |||||
|
Prepaid expenses and other current
assets
|
14,125 | 13,000 | |||||
|
Assets of discontinued
operations
|
2,002 | 2,600 | |||||
|
Total current
assets
|
548,784 | 532,968 | |||||
|
Property and equipment,
net
|
339,793 | 348,013 | |||||
|
Long-term
investments
|
43,325 | 58,604 | |||||
|
Intangible assets,
net
|
118,890 | 125,037 | |||||
|
Goodwill
|
248,365 | 244,003 | |||||
|
Other
assets
|
7,342 | 4,782 | |||||
|
Total
assets
|
$ | 1,306,499 | $ | 1,313,407 | |||
|
Liabilities and Shareholders'
Equity:
|
|||||||
|
Current
liabilities:
|
|||||||
|
Accounts payable,
trade
|
$ | 43,988 | $ | 37,402 | |||
|
Accrued salaries and
wages
|
15,206 | 13,471 | |||||
|
Income taxes
payable
|
9,780 | 5,314 | |||||
| Deferred income taxes | 1,178 | - | |||||
|
Other current
liabilities
|
4,631 | 7,938 | |||||
| Contingent payment due related to LLF acquisition | 4,400 | - | |||||
| Contingent payment due related to COTCO acquisition | - | 60,000 | |||||
|
Liabilities of discontinued
operations
|
480 | 550 | |||||
|
Total current
liabilities
|
79,663 | 124,675 | |||||
|
Long-term
liabilities:
|
|||||||
|
Deferred income
taxes
|
45,123 | 38,048 | |||||
|
Other long-term
liabilities
|
4,212 | 4,199 | |||||
|
Long-term liabilities of
discontinued operations
|
834 | 745 | |||||
|
Total long-term
liabilities
|
50,169 | 42,992 | |||||
|
Shareholders'
Equity:
|
|||||||
|
Common
stock
|
110 | 110 | |||||
|
Additional
paid-in-capital
|
823,762 | 811,015 | |||||
|
Accumulated other comprehensive
income
|
10,488 | 8,923 | |||||
|
Retained
earnings
|
342,307 | 325,692 | |||||
|
Total shareholders'
equity
|
1,176,667 | 1,145,740 | |||||
|
Total liabilities and
shareholders' equity
|
$ | 1,306,499 | $ | 1,313,407 | |||
|
The
following is a reconciliation showing how Cree, Inc.'s second quarter
income statements for fiscal 2009 and 2008 would appear if they were
adjusted for the items noted below.
|
||||||||||||||||||||
|
CREE,
INC.
|
||||||||||||||||||||
|
Reconciling
Items to Q2 2009 & 2008 Financial Statements - GAAP to
Non-GAAP
|
||||||||||||||||||||
|
(in
thousands, except per share amounts)
|
||||||||||||||||||||
|
(Unaudited)
|
||||||||||||||||||||
|
Three
Months Ended
|
Three
Months Ended
|
|||||||||||||||||||
|
December
28, 2008
|
December
30, 2007
|
|||||||||||||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||
|
Product
revenue
|
$ | 137,595 | $ | - | $ | 137,595 | $ | 111,341 | $ | - | $ | 111,341 | ||||||||
|
Contract
revenue
|
4,446 | - | 4,446 | 7,658 | - | 7,658 | ||||||||||||||
|
Up-front
license fees
|
5,582 | - | 5,582 | - | - | - | ||||||||||||||
|
Total
revenue
|
147,623 | - | 147,623 | 118,999 | - | 118,999 | ||||||||||||||
|
Cost
of product revenue
|
86,831 | (883 | ) |
(a)
|
85,948 | 71,251 | (726 | ) |
(a)
|
70,525 | ||||||||||
|
Cost
of contract revenue
|
3,790 | - | 3,790 | 5,952 | - | 5,952 | ||||||||||||||
|
Cost
of up-front license fees
|
506 | - | 506 | - | - | - | ||||||||||||||
|
Total
cost of sales
|
91,127 | (883 | ) | 90,244 | 77,203 | (726 | ) | 76,477 | ||||||||||||
|
Gross
margin
|
56,496 | 883 | 57,379 | 41,796 | 726 | 42,522 | ||||||||||||||
|
Gross
margin percentage
|
38.3 | % | 38.9 | % | 35.1 | % | 35.7 | % | ||||||||||||
|
Operating
expenses:
|
||||||||||||||||||||
|
Research
and development
|
18,441 | (1,247 | ) |
(a)
|
17,194 | 14,901 | (1,039 | ) |
(a)
|
13,862 | ||||||||||
|
Sales,
general and administrative
|
21,843 | (2,979 | ) |
(a)
|
18,864 | 18,211 | (1,492 | ) |
(a),
(d)
|
16,719 | ||||||||||
|
Amortization
of acquisition related intangibles
|
4,062 | (4,062 | ) |
(b)
|
- | 4,048 | (4,048 | ) |
(b)
|
- | ||||||||||
|
Gain
on disposal of assets
|
645 | - | 645 | 474 | - | 474 | ||||||||||||||
|
Total
operating expenses
|
44,991 | (8,288 | ) | 36,703 | 37,634 | (6,579 | ) | 31,055 | ||||||||||||
|
Operating
income
|
11,505 | 9,171 | 20,676 | 4,162 | 7,305 | 11,467 | ||||||||||||||
|
Operating
income percentage
|
7.8 | % | 14.0 | % | 3.5 | % | 9.6 | % | ||||||||||||
|
Non-operating
income:
|
||||||||||||||||||||
|
Gain
on investments in securities
|
53 | - | 53 | - | - | - | ||||||||||||||
|
Interest
and other non-operating income, net
|
2,507 | - | 2,507 | 4,582 | - | 4,582 | ||||||||||||||
|
Income
from continuing operations before income taxes
|
14,065 | 9,171 | 23,236 | 8,744 | 7,305 | 16,049 | ||||||||||||||
|
Income
tax expense
|
3,218 | 2,098 |
(c)
|
5,316 | 2,104 | 1,753 |
(e)
|
3,857 | ||||||||||||
|
Net
income from continuing operations
|
10,847 | 7,073 | 17,920 | 6,640 | 5,552 | 12,192 | ||||||||||||||
|
Loss
from discontinued operations, net of related tax
|
(151 | ) | - | (151 | ) | (20 | ) | - | (20 | ) | ||||||||||
|
Net
income
|
$ | 10,696 | $ | 7,073 | $ | 17,769 | $ | 6,620 | $ | 5,552 | $ | 12,172 | ||||||||
|
Earnings
per diluted share:
|
||||||||||||||||||||
|
From
continuing operations
|
$ | 0.12 | $ | 0.07 | $ | 0.20 | $ | 0.08 | $ | 0.06 | $ | 0.14 | ||||||||
|
From
discontinued operations
|
$ | (0.00 | ) | $ | - | $ | (0.00 | ) | $ | (0.00 | ) | $ | - | $ | (0.00 | ) | ||||
|
From
net income
|
$ | 0.12 | $ | 0.07 | $ | 0.20 | $ | 0.08 | $ | 0.06 | $ | 0.14 | ||||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, basic
|
88,057 | - | 88,057 | 85,190 | - | 85,190 | ||||||||||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, diluted
|
88,511 | - | 88,511 | 86,848 | - | 86,848 | ||||||||||||||
|
(a)
Non-cash stock-based compensation expense of $883 in costs of product
revenue, $1,247 in research and development and $2,979 in sales, general
and administrative for the three months ended December 28, 2008 and $726
in costs of product revenue, $1,039 in research and development and $2,174
in sales, general and administrative for the three months ended December
30, 2007.
|
||||||||||||||||||||
|
(b)
Amortization expense of $4,062 for the three months ended December 28,
2008 and $4,048 for the three months ended December 30, 2007 recognized on
intangible assets resulting from acquisitions.
|
||||||||||||||||||||
|
(c)
Estimated tax effects of non-cash stock-based compensation expense and
amortization related to acquisition related intangible assets based upon
the Company's effective tax rate for the given period.
|
||||||||||||||||||||
|
(d)
Reversal of $682 in personal property assessment related to settling the
audits of the Company's 2002 through 2007 property tax returns with the
County of Durham, NC.
|
||||||||||||||||||||
|
(e)
Estimated tax effects of non-cash stock-based compensation expense,
amortization related to acquisition related intangible assets and the
reversal of a portion of the amount accrued related to our personal
property tax assessments based upon the Company's overall consolidated
effective tax rate for the given
period.
|
||||||||||||||||||||
|
The
following is a reconciliation showing how Cree, Inc.'s year to date income
statements for fiscal 2009 and 2008 would appear if they were adjusted for
the items noted below.
|
||||||||||||||||||||
|
CREE,
INC.
|
||||||||||||||||||||
|
Reconciling
Items to Six Months Financial Statements - GAAP to
Non-GAAP
|
||||||||||||||||||||
|
(in thousands,
except per share
amounts)
|
||||||||||||||||||||
|
(Unaudited)
|
||||||||||||||||||||
|
Six
Months Ended
|
Six
Months Ended
|
|||||||||||||||||||
|
December
28, 2008
|
December
30, 2007
|
|||||||||||||||||||
| GAAP | Adjustments | As Adjusted | GAAP | Adjustments | As Adjusted | |||||||||||||||
|
Product
revenue
|
$ | 272,288 | $ | - | $ | 272,288 | $ | 217,304 | $ | - | $ | 217,304 | ||||||||
|
Contract
revenue
|
10,131 | - | 10,131 | 15,081 | - | 15,081 | ||||||||||||||
|
Up-front
license fees
|
5,582 | - | 5,582 | - | - | - | ||||||||||||||
|
Total
revenue
|
288,001 | - | 288,001 | 232,385 | - | 232,385 | ||||||||||||||
|
Cost
of product revenue
|
173,475 | (2,185 | ) |
(a)
|
171,290 | 143,831 | (1,640 | ) |
(a)
|
142,191 | ||||||||||
|
Cost
of contract revenue
|
8,161 | - | 8,161 | 12,018 | - | 12,018 | ||||||||||||||
|
Cost
of up-front license fees
|
506 | - | 506 | - | - | - | ||||||||||||||
|
Total
cost of sales
|
182,142 | (2,185 | ) | 179,957 | 155,849 | (1,640 | ) | 154,209 | ||||||||||||
|
Gross
margin
|
105,859 | 2,185 | 108,044 | 76,536 | 1,640 | 78,176 | ||||||||||||||
|
Gross
margin percentage
|
37 | % | 38 | % | 33 | % | 34 | % | ||||||||||||
|
Operating
expenses:
|
||||||||||||||||||||
|
Research
and development
|
35,716 | (2,693 | ) |
(a)
|
33,023 | 27,678 | (1,936 | ) |
(a)
|
25,742 | ||||||||||
|
Sales,
general and administrative
|
44,761 | (5,664 | ) |
(a)
|
39,097 | 36,373 | (4,656 | ) |
(a),
(d)
|
31,717 | ||||||||||
|
Amortization
of acquisition related intangibles
|
8,124 | (8,124 | ) |
(b)
|
- | 8,096 | (8,096 | ) |
(b)
|
- | ||||||||||
|
Loss
on disposal and impairment of long-lived assets
|
1,050 | - | 1,050 | 1,209 | - | 1,209 | ||||||||||||||
|
Total
operating expenses
|
89,651 | (16,481 | ) | 73,170 | 73,356 | (14,688 | ) | 58,668 | ||||||||||||
|
Operating
income
|
16,208 | 18,666 | 34,874 | 3,180 | 16,328 | 19,508 | ||||||||||||||
|
Operating
income percentage
|
5.6 | % | 12.1 | % | 1.4 | % | 8.4 | % | ||||||||||||
|
Non-operating
income:
|
||||||||||||||||||||
|
Gain
(loss) on investments in securities
|
65 | - | 65 | 14,117 | (14,117 | ) |
(e)
|
- | ||||||||||||
|
Interest
and other non-operating income, net
|
5,484 | - | 5,484 | 8,309 | - | 8,309 | ||||||||||||||
|
Income
from continuing operations before income taxes
|
21,757 | 18,666 | 40,423 | 25,606 | 2,211 | 27,817 | ||||||||||||||
|
Income
tax expense
|
4,972 | 4,338 |
(c)
|
9,310 | 6,098 | 547 |
(f)
|
6,645 | ||||||||||||
|
Net
income from continuing operations
|
16,785 | 14,328 | 31,113 | 19,508 | 1,664 | 21,172 | ||||||||||||||
|
Loss
from discontinued operations, net of related tax
|
(170 | ) | - | (170 | ) | (174 | ) | - | (174 | ) | ||||||||||
|
Net
income
|
$ | 16,615 | $ | 14,328 | $ | 30,943 | $ | 19,334 | $ | 1,664 | $ | 20,998 | ||||||||
|
Earnings
per diluted share:
|
||||||||||||||||||||
|
From
continuing operations
|
$ | 0.19 | $ | 0.16 | $ | 0.35 | $ | 0.22 | $ | 0.02 | $ | 0.24 | ||||||||
|
From
discontinued operations
|
$ | (0.00 | ) | $ | - | $ | (0.00 | ) | $ | (0.00 | ) | $ | - | $ | (0.01 | ) | ||||
|
From
net income
|
$ | 0.19 | $ | 0.16 | $ | 0.35 | $ | 0.22 | $ | 0.02 | $ | 0.24 | ||||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, basic
|
87,954 | - | 87,954 | 84,936 | - | 84,936 | ||||||||||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, diluted
|
88,619 | - | 88,619 | 86,713 | - | 86,713 | ||||||||||||||
|
(a)
Non-cash stock-based compensation expense of $2,185 in costs of product
revenue, $2,693 in research and development and $5,664 in sales, general
and administrative for the six months ended December 28, 2008 and $1,640
in costs of product revenue, $1,936 in research and development and $3,068
in sales, general and administrative for the six months ended December 30,
2007.
|
||||||||||||||||||||
|
(b) Amortization
expense of $8,124 for the six months ended December 28, 2008 and $8,096
for the six months ended December 30, 2007 recognized on intangible assets
resulting from prior year acquisitions.
|
||||||||||||||||||||
|
(c)
Estimated tax effects of non-cash stock-based compensation expense and
amortization related to acquisition related intangible assets based upon
the Company's effective tax rate for the given period.
|
||||||||||||||||||||
|
(d)
Personal property assessment of $1,048 related to finalizing the audits of
the Company's 2002 through 2007 property tax returns.
|
||||||||||||||||||||
|
(e)
Gain on the sale of 500,000 shares of Color Kinetics Incorporated common
stock during the six months ended December 30, 2007.
|
||||||||||||||||||||
|
(f)
Estimated tax effects of non-cash stock-based compensation expense,
personal property tax assessment, amortization related to acquisition
related intangible assets and gain on sale of Color Kinetics Incorporated
common stock based upon the Company's overall consolidated effective tax
rate for the given
period.
|
||||||||||||||||||||